Top Markets
Coin of the day
MultiCell Technologies, Inc. MultiCell Technologies, Inc.

MultiCell Technologies, Inc.

MCET
Pozycja w akcjach #20716
MultiCell Technologies, Inc., a biopharmaceutical company, develops novel... MultiCell Technologies, Inc., a biopharmaceutical company, develops novel therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer, and interventional cardiology and peripheral vessel applications. Its product portfolio comprises MCT-125, a Phase II therapeutic candidate for the treatment of primary multiple sclerosis-related fatigue; MCT-465, a preclinical synthetic double-stranded RNA (dsRNA) therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers; and MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of various cancers. The company also develops Ideal BioStent, a bioabsorbable stent for interventional cardiology and peripheral vessel applications. MultiCell Technologies, Inc. has a license agreement with Corning Incorporated and Pfizer Inc. The company was formerly known as Exten Industries, Inc. and changed its name to MultiCell Technologies, Inc. in April 2004. MultiCell Technologies, Inc. was founded in 1962 and is headquartered in Woonsocket, Rhode Island.
Cena akcji
$0.00001
Kapitalizacja rynkowa
$50.01K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel MultiCell Technologies, Inc. (MCET)

Kategoria

Historia ceny akcji dla MultiCell Technologies, Inc. (MCET)
Najwyższa cena zamknięcia: $0.00 dnia 2026-03-01

Najniższa cena zamknięcia: $0.70 dnia 2000-01-01
Historia cen akcji firmy MultiCell Technologies, Inc. od 2000 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 0.00%
2024 -76.06%
2023 -58.24%
2022 0.00%
2021 -58.10%
2020 156.99%
2019 -7.14%
2018 -41.18%
2017 -16.78%
2016 -6.37%
2015 -36.84%
2014 -38.00%
2013 -58.42%
2012 -72.33%
2011 13.46%
2010 -68.39%
2009 150.51%
2008 -86.27%
2007 -83.63%
2006 -60.50%
2005 -31.77%
2004 -70.68%
2003 719.22%
2002 -33.40%
2001 -14.26%
2000 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$38.44 -50.17%
DK
$462.49 -8.38%
US
$756.26 13.40%
US
$302.35 54.55%
BE
$99.21 -36.97%
AU